Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to determine the safety, tolerability, and efficacy of three doses of lecozotan SR 2, 5, 10 mg in combination with a cholinesterase inhibitor in patients with mild to moderate Alzheimer s Disease over 24 weeks.
Inclusion criteria
- Alzheimer s Desease